arrow
返回
H

Hannah M. Linden

university of washington

39H指数
239论文数
5.4K被引数
收录论文 89
发表时间
Clinical utility of [18F]fluoroestradiol PET/CT to guide second line treatment decision in ER-positive HER2-negative metastatic breast cancer after progression on first line endocrine therapy[18F]氟雌二醇 PET/CT 在指导内分泌治疗后进展的 ER 阳性 HER2 阴性转移性乳腺癌二线治疗决策中的临床应用价值
err2026-09-18
err0
PREAI
errHannah M. Linden; Sophia R. O’Brien; Stephanie M. van de Ven; Paul La Porte; Peter S. Conti; Parvin F. Peddi; Joanne E. Mortimer; Christiana Brenin; Amol M. Takalkar; Julia E. McGuinness; Edgar Cheng; Amol Rao; Lanell M. Peterson; Jennifer M. Specht; Terence Z. Wong; David A. Buck; Adam M. Brufsky; Gary A. Ulaner
err分享
err收藏
Perspective of Hispanic Cancer Survivors on Survivorship Care Plans: A Qualitative Study西班牙裔癌症幸存者对幸存者护理计划的看法:一项定性研究
err2025-10-01
err0
PREAI
errYi, Jean C.; Lee, Ethan; Duggan, Catherine; Baker, K. Scott; Blythe, Nancy; Cole, Allison M.; Cushing-Haugen, Kara L.; Gutierrez, Adrianna I.; Linden, Hannah; Mendoza, Jason A.; Ohlsen, Timothy J. D.; Ortblad, Katrina F.; Schwartz, Stephen M.; Yung, Rachel; Ceballos, Rachel; Chow, Eric J.
err分享
err收藏
Zanidatamab plus palbociclib and fulvestrant in previously treated patients with hormone receptor-positive, HER2-positive metastatic breast cancer: primary results from a two-part, multicentre, single-arm, phase 2a studyZanidatamab联合palbociclib和fulvestrant治疗既往接受过治疗的激素受体阳性、HER2阳性转移性乳腺癌:一项两阶段、多中心、单臂、2a期研究的主要结果
err2025-05-05
err0
PREAI
errSantiago Escrivá-de-Romani; Juan M Cejalvo; Emilio Alba; Jennifer Friedmann; Álvaro Rodríguez-Lescure; Marie-France Savard; Rossanna C Pezo; Maria Gion; Manuel Ruiz-Borrego; Erika Hamilton; Timothy Pluard; Marc Webster; Muralidhar Beeram; Hannah Linden; Cristina Saura; Diana Shpektor; Bob Salim; Phoebe Harvey; Sara A Hurvitz
err分享
err收藏
Fluoroestradiol (FES) and Fluorodeoxyglucose (FDG) PET imaging in patients with ER+, HER2-positive or HER2-negative metastatic breast cancerER,HER2-positive或HER2-negative转移性乳腺癌患者的氟雌二醇 (FES) 和氟脱氧葡萄糖 (FDG) PET成像
err2025-02-17
err0
errOAAI
errHunter, Natasha B.; Peterson, Lanell M.; Specht, Jennifer M.; Mankoff, David A.; Muzi, Mark; Chen, Delphine L.; Gwin, William R.; Vinayak, Shaveta; Davidson, Nancy E.; Linden, Hannah M.
err分享
err收藏
Enhancing survivorship care among Hispanic/Latino cancer survivors via lay health educators: results of a pilot randomized trial通过非专业健康教育者加强西班牙裔/拉丁美洲癌症幸存者的生存护理: 一项随机试验的结果
err2025-02-15
err0
PREAI
errChow, Eric J.; Blythe, Nancy A.; Cushing-Haugen, Kara L.; Duggan, Catherine; Baker, K. Scott; Cole, Allison M.; Green, Spencer; Guiterrez, Adrianna I.; Lee, Ethan; Linden, Hannah M.; Mendoza, Jason A.; Ohlsen, Timothy J. D.; Ortblad, Katrina F.; Schwartz, Stephen M.; Yung, Rachel L.; Ceballos, Rachel M.
err分享
err收藏
Metabolic Syndrome and Risks of Breast Cancer Outcomes for Luminal, Triple-Negative, and HER2-Overexpressing Subtypes
err2024-11-01
err0
PREAI
errLorona, Nicole C.; Othus, Megan; Malone, Kathleen E.; Linden, Hannah M.; Tang, Mei-Tzu C.; Li, Christopher I.
err分享
err收藏
Primary results from a phase 2a study of zanidatamab (zani) plus palbociclib (palbo) plus fulvestrant (fulv) in HER2+/HR+ metastatic breast cancer (mBC)
err2024-05-02
err0
PREAI
errEscriva-de-Romani, Santiago; Cejalvo, Juan Miguel; Alba, Emilio; Friedmann, Jennifer; Lescure, Alvaro Rodriguez; Savard, Marie-France; Pezo, Rossanna C.; Gion, Maria; -Borrego, Manuel Ruiz; Hamilton, Erika; Pluard, Timothy; Webster, Marc; Beeram, Muralidhar; Linden, Hannah; Saura, Cristina; Shpektor, Diana; Salim, Bob; Harvey, Phoebe; Hurvitz, Sara
err分享
err收藏
Concurrent chemotherapy with adjuvant radiation for patients with high-risk locally advanced breast cancer: safety and outcomes
err2024-05-02
err0
PREAI
errSymonds, Lynn; Swenson, Sasha; Nguyen, Macklin; Hippe, Daniel; Linden, Hannah; Specht, Jennifer M.; Gwin, WIlliam; Kim, Janice
err分享
err收藏
Genomic Landscape of ER positive HER2-low early breast cancers in the FLEX Study: MammaPrint, BluePrint and whole transcriptome analysis
err2024-05-02
err0
PREAI
errSivapiragasam, Abirami; Brufsky, Adam; Linden, Hannah; Hunter, Natasha; Osborne, Cynthia; Diab, Sami; Maganini, Robert; O'Shaughnessy, Joyce; Bupathi, Manojkumar; Lee, Sung Ho; Kim, Theodore Y.; Audeh, William; Haan, Josien; Menicucci, Andrea; Samraj, Lavanya
err分享
err收藏
Design of Active Phase 3 ENABLAR-2 Study Evaluating Enobosarm plus /- Abemaciclib in Patients with AR+ER+HER2-2nd-Line Metastatic Breast Cancer Following Tumor Progression on an Estrogen Blocking Agent Plus Palbociclib or Ribociclib
err2024-05-02
err0
PREAI
errRinn, Kristine; Linden, Hannah; Schwartzberg, Lee; Barnette, Gary; Rodriguez, Domingo; Shalev, Itay; Steiner, Mitchell; Brufsky, Adam; O'Shaughnessy, Joyce
err分享
err收藏
Distribution of MammaPrint, BluePrint, and Response Predictive Subtypes based on ImPrint and Reprint in ER+/HER2-Invasive Lobular Carcinoma - A FLEX sub study
err2024-05-02
err0
PREAI
errMukhtar, Rita; Yau, Christina; Wolf, Denise; Brufsky, Adam; Linden, Hannah; Hunter, Natasha; Mahtani, Reshma; Sivapiragasam, Abirami; Feinstein, Trevor; Yan, Fengting; Grady, Ian; McAuliffe, Priscilla; Tsai, Michaela; O'Shaughnessy, Joyce; Mavromatis, Blanche; Davis, Sasha; Haan, Josien; Audeh, William; Samraj, Lavanya
err分享
err收藏
Repeatability of 18F-FDG uptake in metastatic bone lesions of breast cancer patients and implications for accrual to clinical trials
err2024-03-27
err0
errOAAI
errMuzi, Mark; Peterson, Lanell M.; Specht, Jennifer M.; Hippe, Daniel S.; Novakova-Jiresova, Alena; Lee, Jean H.; Kurland, Brenda F.; Mankoff, David A.; Obuchowski, Nancy; Linden, Hannah M.; Kinahan, Paul E.
err分享
err收藏
Summary: SNMMI Procedure Standard/EANM Practice Guideline for Estrogen Receptor Imaging of Patients with Breast Cancer Using 16a-[18F]Fluoro-17b-Estradiol PET
err2023-12-07
err9
errOAAI
errMankoff, David; Balogova, Sona; Dunnwald, Lisa; Dehdashti, Farrokh; DeVries, Erik; Evangelista, Laura; Van Kruchten, Michel; Vaz, Sofia Carrilho; Fowler, Amy; Linden, Hannah; Ulaner, Gary A.
err分享
err收藏
Alcohol, Smoking, and Risks of Breast Cancer Recurrence and Mortality among Women with Luminal, Triple-Negative, and HER2-Overexpressing Breast Cancer
err2023-11-29
err3
errOAAI
errLorona, Nicole C.; Othus, Megan; Malone, Kathleen E.; Linden, Hannah M.; Tang, Mei-Tzu C.; Li, Christopher I.
err分享
err收藏
Multimodal prediction of neoadjuvant treatment outcome by serial FDG PET and MRI in women with locally advanced breast cancer
err2023-11-09
err5
errOAAI
errKazerouni, Anum S.; Peterson, Lanell M.; Jenkins, Isaac; Novakova-Jiresova, Alena; Linden, Hannah M.; Gralow, Julie R.; Hockenbery, David M.; Mankoff, David A.; Porter, Peggy L.; Partridge, Savannah C.; Specht, Jennifer M.
err分享
err收藏
Estrogen Receptor-Targeted and Progesterone Receptor-Targeted PET for Patients with Breast Cancer
err2023-10-01
err6
PREAI
errUlaner, Gary A.; Fowler, Amy M.; Clark, Amy S.; Linden, Hannah
err分享
err收藏
err分享
err收藏
Summary: Appropriate Use Criteria for Lymphoscintigraphy in Sentinel Node Mapping and Lymphedema/Lipedema
err2023-03-23
err9
errOAAI
errDonohoe, Kevin J.; Carroll, Brett J.; Chung, David K. V.; Dibble, Elizabeth H.; Diego, Emilia; Giammarile, Francesco; Grant, Frederick D.; Lai, Stephen Y.; Linden, Hannah; Miller, Megan E.; Pandit-Taskar, Neeta; Tawa Jr, Nicholas E.; Vidal-Sicart, Sergi
err分享
err收藏
Summary: Appropriate Use Criteria for Estrogen Receptor-Targeted PET Imaging with 16?-18F-Fluoro-17?-Fluoroestradiol
err2023-03-02
err34
errOAAI
errUlaner, Gary A.; Mankoff, David A.; Clark, Amy S.; Fowler, Amy M.; Linden, Hannah M.; Peterson, Lanell M.; Dehdashti, Farrokh; Kurland, Brenda F.; Mortimer, Joanne; Mouabbi, Jason; Moon, Dae Hyuk; de Vries, Elisabeth G. E.
err分享
err收藏